Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcase

Bioorg Chem. 2023 Nov:140:106819. doi: 10.1016/j.bioorg.2023.106819. Epub 2023 Aug 28.

Abstract

A new class of compounds inhibiting de-O-glycosylation of proteins has been identified. Highly substituted diaminocyclopentanes are impressively selective reversible non-transition state O-β-N-acetyl-d-glucosaminidase (O-GlcNAcase) inhibitors. The ease of preparative access and remarkable biological activities provide highly viable leads for the development of anti-tau-phosphorylation agents with a view to eventually ameliorating Alzheimer's disease.

Keywords: Alzheimer’s disease; Diaminocyclopentane; Glycosidase inhibition; O-GlcNAcase.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alzheimer Disease*
  • Glycosylation
  • Hexosaminidases
  • Humans
  • beta-N-Acetylhexosaminidases*

Substances

  • hexosaminidase C
  • beta-N-Acetylhexosaminidases
  • Hexosaminidases